Rouan Sarah Kathryn

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 86% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Rouan Sarah Kathryn's trades of Viking Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-02 2025-03-31
B Purchase
99,461 -36.2%
217.80
US$3,697,641 		99,461 -36.2% 217.80 US$3,697,641
2024-10-25 2024-10-25
PrS Proposed sale
89,877
371.64
US$4,305,140 		89,877 371.64 US$4,305,140
2024-10-25 2024-10-25
PlS Planned sale
36,997 +47.3%
462.16
US$623,298 		36,997 +47.3% 462.16 US$623,298
2024-02-08 2024-02-08
PrS Proposed sale
25,000
28.05
US$701,250 		25,000 28.05 US$701,250
2024-02-08 2024-02-08
PlS Planned sale
25,000 -100.0%
28.05
US$701,250 		25,000 -100.0% 28.05 US$701,250
2024-01-19 2024-01-19
PrS Proposed sale
30,000
23.05
US$691,500 		30,000 23.05 US$691,500
2024-01-19 2024-01-19
PlS Planned sale
30,000 -100.0%
23.05
US$691,500 		30,000 -100.0% 23.05 US$691,500
2019-05-21 2019-05-17
B Purchase
3,350 +67.0%
1.46
US$4,904 		3,350 +67.0% 1.46 US$4,904